Literature DB >> 35924260

TAT&RGD Peptide-Modified Naringin-Loaded Lipid Nanoparticles Promote the Osteogenic Differentiation of Human Dental Pulp Stem Cells.

Chun-Yan Zheng1, Xiao-Yang Chu2, Chun-Yan Gao1, Hua-Ying Hu3, Xin He1, Xu Chen1, Kai Yang4, Dong-Liang Zhang1.   

Abstract

Background: Naringin is a naturally occurring flavanone that promotes osteogenesis. Owing to the high lipophilicity, poor in vivo bioavailability, and extensive metabolic alteration upon administration, the clinical efficacy of naringin is understudied. Additionally, information on the molecular mechanism by which it promotes osteogenesis is limited.
Methods: In this study, we prepared TAT & RGD peptide-modified naringin-loaded nanoparticles (TAT-RGD-NAR-NPs), evaluated their potency on the osteogenic differentiation of human dental pulp stem cells (hDPSCs), and studied its mechanism of action through metabolomic analysis.
Results: The particle size and zeta potential of TAT-RGD-NAR-NPs were 160.70±2.05 mm and -20.77±0.47mV, respectively. The result of cell uptake assay showed that TAT-RGD-NAR-NPs could effectively enter hDPSCs. TAT-RGD-NAR-NPs had a more significant effect on cell proliferation and osteogenic differentiation promotion. Furthermore, in metabolomic analysis, naringin particles showed a strong influence on the glycerophospholipid metabolism pathway of hDPSCs. Specifically, it upregulated the expression of PLA2G3 and PLA2G1B (two isozymes of phospholipase A2, PLA2), increased the biosynthesis of lysophosphatidic acid (LPA).
Conclusion: These results suggested that TAT-RGD-NPs might be used for transporting naringin to hDPSCs for modulating stem cell osteogenic differentiation. The metabolomic analysis was used for the first time to elucidate the mechanism by which naringin promotes hDPSCs osteogenesis by upregulating PLA2G3 and PLA2G1B.
© 2022 Zheng et al.

Entities:  

Keywords:  RGD; TAT; hDPSCs; nanoparticles; osteogenic differentiation

Mesh:

Substances:

Year:  2022        PMID: 35924260      PMCID: PMC9342892          DOI: 10.2147/IJN.S371715

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  64 in total

Review 1.  Regulation of osteoblast formation and function.

Authors:  J E Aubin
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

2.  RGD/TAT-functionalized chitosan-graft-PEI-PEG gene nanovector for sustained delivery of NT-3 for potential application in neural regeneration.

Authors:  Dongni Wu; Yongnu Zhang; Xiaoting Xu; Ting Guo; Deming Xie; Rong Zhu; Shengfeng Chen; Seeram Ramakrishna; Liumin He
Journal:  Acta Biomater       Date:  2018-03-22       Impact factor: 8.947

3.  Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells.

Authors:  Wai-Yin Pang; Xin-Lun Wang; Sau-Keng Mok; Wan-Ping Lai; Hung-Kay Chow; Ping-Chung Leung; Xin-Sheng Yao; Man-Sau Wong
Journal:  Br J Pharmacol       Date:  2010-04       Impact factor: 8.739

Review 4.  Peptides as targeting elements and tissue penetration devices for nanoparticles.

Authors:  Erkki Ruoslahti
Journal:  Adv Mater       Date:  2012-05-02       Impact factor: 30.849

5.  An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction.

Authors:  Carl A Gregory; W Grady Gunn; Alexandra Peister; Darwin J Prockop
Journal:  Anal Biochem       Date:  2004-06-01       Impact factor: 3.365

6.  Transcriptional regulation of bone sialoprotein gene expression by Osx.

Authors:  Ya Yang; Yehong Huang; Li Zhang; Chi Zhang
Journal:  Biochem Biophys Res Commun       Date:  2016-05-31       Impact factor: 3.575

7.  The sequential expression profiles of growth factors from osteoprogenitors [correction of osteroprogenitors] to osteoblasts in vitro.

Authors:  Zhinong Huang; Ehren Robert Nelson; R Lane Smith; Stuart B Goodman
Journal:  Tissue Eng       Date:  2007-09

Review 8.  The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids.

Authors:  Aedín Cassidy; Anne-Marie Minihane
Journal:  Am J Clin Nutr       Date:  2016-11-23       Impact factor: 7.045

Review 9.  Re-appraising the potential of naringin for natural, novel orthopedic biotherapies.

Authors:  Kristin E Yu; Kareme D Alder; Montana T Morris; Alana M Munger; Inkyu Lee; Sean V Cahill; Hyuk-Kwon Kwon; JungHo Back; Francis Y Lee
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-12-08       Impact factor: 5.346

10.  Naringin improves random skin flap survival in rats.

Authors:  Liang Cheng; Tingxiang Chen; Qiming Tu; Hang Li; Zhenghua Feng; Zhijie Li; Dingsheng Lin
Journal:  Oncotarget       Date:  2017-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.